ResearchMoz

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalData
Published Date » 2012-10-08
No. Of Pages » 89
     
  Vertebral Augmentation and Vertebroplasty Devices Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018  
   
   
 GlobalDatas new report, Vertebral Augmentation and Vertebroplasty Devices Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. ...
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction 8
2.1 GlobalData Report Guidance 8

3 Vertebral Compression Fractures - Overview 9
3.1 Epidemiology 9
3.2 Acute and Chronic Symptoms 10
3.3 Treatment Options for VCF 11
3.3.1 Benefits of Vertebral Augmentation over Vertebroplasty 13
3.3.2 Potential Complications 13
3.4 Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices 13

4 Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization 15
4.1 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 20042011 15
4.2 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 20112018 16
4.3 Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends 18
4.3.1 Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies 18
4.3.2 Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers 22
4.3.3 Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth 23
4.4 Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
4.4.1 Market Drivers 30
4.4.2 Market Restraints 38

5 Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 2018 42
5.1 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 20042011 42
5.2 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 20112018 43
5.3 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 20042011 45
5.4 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 20112018 46
5.5 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 20042011 47
5.6 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 20112018 48
5.7 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 20042011 49
5.8 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 20112018 51
5.9 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 20042011 52
5.10 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 20112018 53
5.11 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 20042011 54
5.12 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 20112018 55
5.13 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 20042011 56
5.14 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 20112018 57

6 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment 59
6.1 Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants 60
6.1.1 Medtronic Inc. 60
6.1.2 Stryker Corporation 65
6.1.3 CareFusion 67

7 Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70
7.1 Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes) 70
7.1.1 Product Description 70
7.2 Shield Kyphoplasty System, Soteira 71
7.2.1 Product Description 71
7.3 Kyphoplasty System, BONESUPPORT 71
7.3.1 Product Description 71
7.4 Acu-Cut Vertebral Augmentation System, Ascendx Spine 71
7.4.1 Product Description 71
7.5 V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes) 72
7.5.1 Product Description 72
7.6 Integrated System for Vertebroplasty, Skeltex 72
7.6.1 Product Description 72
7.7 OsseoFix Spinal Fracture Reduction System, Alphatec Spine 72
7.7.1 Product Description 72

8 Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73
8.1 Crosstrees Pod, Crosstrees Medical Inc. 73
8.1.1 Product Description 73
8.1.2 Product Status 73
8.2 Kiva VCF System, Benvenue Medical, Inc. 74
8.2.1 Product Description 74
8.2.2 Product Status 74
8.3 OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc. 74
8.3.1 Product Description 74
8.3.2 Product Status 74
8.4 VerteLift Implant, SpineAlign Medical, Inc. 74
8.4.1 Product Description 74
8.4.2 Product Status 74
8.5 AVAMAX Vertebroplasty Kits, CareFusion 75
8.5.1 Product Description 75
8.5.2 Product Status 75

9 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis 76
9.1 List of Venture Financing Deals 77
9.2 List of Debt Offerings 79
9.3 List of Partnership Deals 80
9.4 List of Equity Offerings Deals 80
9.5 Key Deals 80
9.5.1 Ascendx Spine Entered into Co-Marketing Agreement with Anwerina 80
9.5.2 Benvenue Medical Raised $25m Series D Financing 81
9.5.3 Shanghai Kinetic Medical Completed IPO for $60m 81

10 Appendix 82
10.1 Market Definitions 82
10.1.1 Vertebral Augmentation and Vertebroplasty Devices 82
10.2 Acronyms 82
10.3 Sources 83
10.4 Research Methodology 87
10.4.1 Secondary Research 88
10.4.2 Primary Research 88
10.4.3 Models 88
10.4.4 Forecasts 89
10.4.5 Expert Panels 89
10.5 GlobalData Consulting 89
10.6 Contact Us 89
10.7 Disclaimer 89

List of Tables


Table 1: VCF Prevalence in Cancer Patients 10
Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20042011 15
Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20112018 17
Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009 18
Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 20082010 19
Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 20082011 21
Table 7: FREE (Fracture Reduction Evaluation), 2009 23
Table 8: FREE (Fracture Reduction Evaluation), 2011 24
Table 9: Cancer Patient Fracture Evaluation or CAF

List of Figures


Figure 1: Vertebral Compression Fracture, Treatment Options 11
Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010 13
Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20042011 15
Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 20112018 16
Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 20082010 19
Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 20082011 21
Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 20112018 35
Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 39
Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 20042011 42
Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 20112018 43
Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 20042011 45
Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 20112018 46
Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 20042011 47
Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 20112018 48
Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 20042011 49
Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 20112018 51
Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 20042011 52
Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 20112018 53
Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 20042011 54
Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 20112018 55
Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 20042011 56
Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 20112018 57
Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59
Figure 25: Medtronic, SWOT Analysis 61
Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63
Figure 27: Stryker, SWOT Analysis 65
Figure 28: CareFusion, SWOT Analysis 68
Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 20102012 76

Upcoming Reports:

System-in-Package (SiP) Die Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
System in a Package (SiP) technology created multiple enhanced packaging applications to develop solutions that are capable of being customized depending on the requirement of the user. SiP is a combination of several integrated circuits (ICs) combined in a single module or package. System in a Package gives tangible gains when space reduction is considered. Although system-on-chip (SoC) fulfills the same objective further effectively, their designs are more time consuming and complex than system in a package. SiP's simplicity has unbolted a wide collection of uses for it in...
Alkyl Polyglucosides Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Alkyl polyglucosides are bio surfactants produced by reacting of sugar with fat. Alkyl polyglucosides are non ionic surfactants and are among the recently developed high efficiency bio surfactants. Production process involves one step or two step process; butanol is used to produce butyl glucoside which is then reacted with fatty alcohol in the two step process. Corn starch and fatty alcohol are among the major raw material sources employed in the one step process. One step process is the dominant process used in the production of alkyl polyglucosides. Major application segments for alkyl...
Fluorotelomers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Fluorotelomers are telomers or oligomers based on fluorocarbons, having few monomer units. Certain fluorotelomers and their compounds serve as raw materials to environmentally persistent perfluorinated carboxylic acids such as perfluorononanoate (PFNA) and perfluorooctanoic acid (PFOA). PFNA and PFOA are primarily used in a wide range of applications across various industries due to their eco-friendly nature and inability to bioaccumulate in animals.  Different types of fluorotelomers are used in the industry such as fluorotelomers iodide, fluorotelomers alcohol, and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...